• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Medical and surgical treatment of neovascular glaucoma.

作者信息

Olmos Lisa C, Lee Richard K

出版信息

Int Ophthalmol Clin. 2011 Summer;51(3):27-36. doi: 10.1097/IIO.0b013e31821e5960.

DOI:10.1097/IIO.0b013e31821e5960
PMID:21633236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3107497/
Abstract
摘要

相似文献

1
Medical and surgical treatment of neovascular glaucoma.新生血管性青光眼的药物及手术治疗
Int Ophthalmol Clin. 2011 Summer;51(3):27-36. doi: 10.1097/IIO.0b013e31821e5960.
2
Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.抗血管内皮生长因子药物玻璃体腔内注射联合保守滤过手术治疗新生血管性青光眼的疗效观察。
J Glaucoma. 2010 Mar;19(3):212-8. doi: 10.1097/IJG.0b013e3181aae928.
3
Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.玻璃体内注射贝伐单抗治疗难治性新生血管性青光眼：一项前瞻性观察性病例系列研究。
Arch Ophthalmol. 2011 Feb;129(2):145-50. doi: 10.1001/archophthalmol.2010.350.
4
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.玻璃体内注射贝伐单抗治疗41例连续性缺血性视网膜疾病继发的虹膜新生血管和新生血管性青光眼。
Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28.
5
[Results in neovascular glaucoma treatment].[新生血管性青光眼治疗的结果]
Oftalmologia. 2011;55(2):98-100.
6
Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.全视网膜光凝、玻璃体内注射贝伐单抗联合随后的丝裂霉素 C 小梁切除术治疗新生血管性青光眼。
J Glaucoma. 2010 Dec;19(9):622-6. doi: 10.1097/IJG.0b013e3181ccb794.
7
The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.不同剂量前房内注射贝伐单抗对新生血管性青光眼小梁切除术手术效果的影响
Eur J Ophthalmol. 2010 Jan-Feb;20(1):251; author reply 252. doi: 10.1177/112067211002000144.
8
[Treatment of neovascular glaucoma].[新生血管性青光眼的治疗]
Oftalmologia. 2012;56(3):20-39.
9
Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma.前房内注射贝伐单抗治疗新生血管性青光眼后的视网膜循环障碍
Acta Ophthalmol. 2008 Dec;86(8):927-8. doi: 10.1111/j.1755-3768.2008.01187.x. Epub 2008 May 20.
10
Bevacizumab as adjuvant for neovascular glaucoma.贝伐单抗作为新生血管性青光眼的辅助治疗。
Acta Ophthalmol. 2010 Feb;88(1):103-9. doi: 10.1111/j.1755-3768.2008.01355.x. Epub 2009 Sep 20.

引用本文的文献

1
Iris cerclage with goniosynechialysis and canalicular stent for neovascular angle closure glaucoma.虹膜环扎术联合前房角粘连分离术及泪小管支架植入术治疗新生血管性闭角型青光眼
Am J Ophthalmol Case Rep. 2025 Aug 5;39:102393. doi: 10.1016/j.ajoc.2025.102393. eCollection 2025 Sep.
2
Effectiveness and safety of intravitreal aflibercept injection for neovascular glaucoma: A single-center, retrospective, observational study in China.玻璃体内注射阿柏西普治疗新生血管性青光眼的有效性和安全性：中国一项单中心、回顾性、观察性研究
Medicine (Baltimore). 2025 Feb 28;104(9):e41538. doi: 10.1097/MD.0000000000041538.
3
Peripheral Retinal Ischemia and Secondary Neovascular Glaucoma after Cerclage for Retinal Detachment: A Case Report.视网膜脱离环扎术后周边视网膜缺血与继发性新生血管性青光眼：一例报告
Case Rep Ophthalmol. 2025 Jan 7;16(1):86-94. doi: 10.1159/000543239. eCollection 2025 Jan-Dec.
4
Long-term outcome of surgical management in neovascular glaucoma: A retrospective, multicentric study.新生血管性青光眼手术治疗的长期疗效：一项回顾性多中心研究。
Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S254-S259. doi: 10.4103/IJO.IJO_3145_23. Epub 2024 Aug 14.
5
Intraocular lens selection in diabetic patients: How to increase the odds for success.糖尿病患者的人工晶状体选择：如何提高成功几率。
World J Diabetes. 2024 Jun 15;15(6):1199-1211. doi: 10.4239/wjd.v15.i6.1199.
6
Surgical outcomes including visual improvement after glaucoma surgery in patients with neovascular glaucoma.手术结果，包括新生血管性青光眼患者青光眼手术后的视力改善情况。
Heliyon. 2024 Mar 30;10(7):e28938. doi: 10.1016/j.heliyon.2024.e28938. eCollection 2024 Apr 15.
7
Trabeculectomy with concurrent intravitreal bevacizumab in neovascular glaucoma.新生血管性青光眼的小梁切除术联合玻璃体内注射贝伐单抗。
Indian J Ophthalmol. 2024 Mar 1;72(3):386-390. doi: 10.4103/IJO.IJO_676_23. Epub 2023 Dec 15.
8
IL-17A Enhances Retinal Neovascularization.IL-17A 增强视网膜新生血管形成。
Int J Mol Sci. 2023 Jan 16;24(2):1747. doi: 10.3390/ijms24021747.
9
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.新生血管性青光眼：病因、发病机制、诊断与治疗的综述。
Medicina (Kaunas). 2022 Dec 18;58(12):1870. doi: 10.3390/medicina58121870.
10
Pars plana vitrectomy combined with pan-retinal photocoagulation, Ahmed glaucoma valve implantation, and/or phacoemulsification for complicated neovascular glaucoma treatment.玻璃体切割联合全视网膜光凝、艾哈迈德青光眼引流阀植入和/或超声乳化术治疗复杂性新生血管性青光眼。
Arq Bras Oftalmol. 2022 Sep 23;87(1):0187. doi: 10.5935/0004-2749.2021-0187. eCollection 2022.

本文引用的文献

1
Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy. Ahmed 青光眼阀植入术治疗增生性糖尿病视网膜病变玻璃体切除术后新生血管性青光眼。
J Glaucoma. 2011 Sep;20(7):433-8. doi: 10.1097/IJG.0b013e3181f3eb06.
2
Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.玻璃体内联合应用贝伐单抗和小梁切除术联合丝裂霉素 C 与单独小梁切除术联合丝裂霉素 C 治疗新生血管性青光眼。
J Glaucoma. 2011 Mar;20(3):196-201. doi: 10.1097/IJG.0b013e3181d9ce12.
3
Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.玻璃体内注射贝伐单抗联合全视网膜光凝治疗开角型新生血管性青光眼。
Eur J Ophthalmol. 2009 Nov-Dec;19(6):1028-33. doi: 10.1177/112067210901900620.
4
Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.玻璃体内注射贝伐单抗治疗新生血管性青光眼：一项随机对照试验。
J Glaucoma. 2009 Oct-Nov;18(8):632-7. doi: 10.1097/IJG.0b013e3181997211.
5
Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.新生血管性青光眼行小梁切除术前行玻璃体内注射贝伐单抗的疗效观察。
Acta Ophthalmol. 2010 Feb;88(1):96-102. doi: 10.1111/j.1755-3768.2009.01648.x. Epub 2009 Sep 23.
6
Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.玻璃体内注射贝伐单抗与房水引流手术治疗新生血管性青光眼：安全性与疗效
Can J Ophthalmol. 2009 Aug;44(4):451-6. doi: 10.3129/i09-108.
7
Contact transscleral cyclophotocoagulation in the treatment of neovascular glaucoma: a five-year follow-up.经巩膜睫状体光凝术治疗新生血管性青光眼的五年随访
Med Sci Monit. 2009 Mar;15(3):BR84-7.
8
Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.丝裂霉素C辅助小梁切除术治疗新生血管性青光眼：手术失败的预后因素
Am J Ophthalmol. 2009 May;147(5):912-8, 918.e1. doi: 10.1016/j.ajo.2008.11.015. Epub 2009 Feb 5.
9
Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.玻璃体内注射贝伐单抗治疗新生血管性青光眼的疗效
Br J Ophthalmol. 2009 May;93(5):589-93. doi: 10.1136/bjo.2008.151472. Epub 2008 Dec 15.
10
Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.玻璃体腔内注射贝伐单抗联合全视网膜光凝与单纯全视网膜光凝治疗新生血管性青光眼的比较
Retina. 2008 May;28(5):696-702. doi: 10.1097/IAE.0b013e3181679c0b.